West Yorkshire and Harrogate Cancer Alliance
West Yorkshire and Harrogate Cancer Alliance is an NHS-funded Cancer Alliance coordinating cancer diagnosis, treatment, and care transformation across West Yorkshire and Harrogate, serving patients, six NHS hospital trusts, primary care, and VCSE partners through screening, innovation funding, workforce development, and community engagement programmes.
- Company typePublic
- Founded2016
- HeadquartersWakefield, England, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingServices
What West Yorkshire and Harrogate Cancer Alliance does
West Yorkshire and Harrogate Cancer Alliance is an NHS-funded public sector organisation established in 2016 as one of 21 Cancer Alliances across England, operating as the cancer programme of the West Yorkshire Integrated Care Board within the West Yorkshire Health and Care Partnership. Headquartered in Wakefield with a team of 38, it coordinates the transformation of cancer diagnosis, treatment, and care across the West Yorkshire and Harrogate region, working in partnership with six NHS hospital trusts, primary care, voluntary sector organisations, and patient groups. Its core service portfolio spans screening (Targeted Lung Health Checks, FIT pathway), the Living with and Beyond Cancer programme, workforce development (Macmillan CNS Development Programme and ACCEND), innovation funding (up to £800k annually), genomics services, non-surgical oncology coordination, and community engagement via Cancer Champions and an award-winning Community Patient Panel.
The organisation's underlying technology is a healthcare coordination and transformation platform within the NHS ecosystem, relying on standard third-party web integrations (Google Analytics, YouTube/Vimeo, Google Maps, Google reCAPTCHA, Google Translate) rather than proprietary AI or software IP. Programmes are delivered through partnerships with regional NHS trusts, Macmillan Cancer Support, Yorkshire Cancer Community, Dementia Forward, Leeds Beckett University, and other VCSE organisations.
West Yorkshire and Harrogate Cancer Alliance does not generate commercial revenue. It is funded by NHS England and operates as a managed-services programme under a statutory mandate to reduce cancer health inequalities, accelerate early diagnosis, and improve patient experience and outcomes. Pricing is non-commercial; funding flows through the West Yorkshire Integrated Care Board and is distributed via innovation competitions, workforce investments, and partnership grants. The Alliance's growth is constrained by NHS funding settlements and policy priorities rather than market demand.
West Yorkshire and Harrogate Cancer Alliance firmographics
Firmographics- Name
- West Yorkshire and Harrogate Cancer Alliance
- Legal name
- West Yorkshire and Harrogate Cancer Alliance
- Website
- https://canceralliance.wyhpartnership.co.uk
- Company type
- Public
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- West Yorkshire and Harrogate Cancer Alliance is an NHS-funded Cancer Alliance coordinating cancer diagnosis, treatment, and care transformation across West Yorkshire and Harrogate, serving patients, six NHS hospital trusts, primary care, and VCSE partners through screening, innovation funding, workforce development, and community engagement programmes.
- Ownership category
- akta.pro rank
West Yorkshire and Harrogate Cancer Alliance industry classification
Industry- Product category
- Cancer Care Coordination Services
- NAICS
- Social Assistance (624)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Oncology & Cancer Specialty Hospitals (HLAFAHAC)
- akta.pro secondary industry
- Community Health, Prevention & Health Education (BPAGACAC)
Keywords
Where West Yorkshire and Harrogate Cancer Alliance is headquartered
LocationHeadquarters
- HQ city
- Wakefield, England
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
West Yorkshire and Harrogate Cancer Alliance business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Others, Technology or R&D
Revenue model
- NHS England Funding: As one of 21 Cancer Alliances across England, funded by NHS England to transform cancer diagnosis, treatment and care in the West Yorkshire and Harrogate area.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels8 records
West Yorkshire and Harrogate Cancer Alliance product offering
Product offeringCore offering
West Yorkshire and Harrogate Cancer Alliance is an NHS-funded cancer transformation programme that coordinates and improves cancer diagnosis, treatment and care across the West Yorkshire and Harrogate region. It delivers and oversees a portfolio of interconnected programmes including early diagnosis and screening (e.g., Targeted Lung Health Checks, FIT pathway), personalised care and living with and beyond cancer support, an annual innovation funding competition (up to £800k), workforce development (Macmillan CNS Development Programme, ACCEND) and community engagement through Cancer Champions and the Community Patient Panel. The offering is publicly funded, free at point of use, and directed at NHS Trusts, healthcare professionals, patients, carers and communities across the region.
Product overview
West Yorkshire and Harrogate Cancer Alliance is a NHS-funded cancer programme operating as a network of coordinated care initiatives rather than a commercial product. The organisation coordinates cancer services across West Yorkshire and Harrogate through multiple interconnected programmes including the Living with and Beyond Cancer Programme, NHS Lung Cancer Screening Programme, Innovations Programme (with annual funding competitions up to £800k), and workforce development initiatives such as the ACCEND programme. Patient-facing services include the Cancer Champions volunteer programme, Community Patient Panel, and comprehensive cancer-specific information resources covering 12 cancer types. The organisation also coordinates Optimal Pathway Groups for clinical pathway optimization and provides access to Non Surgical Oncology, Genomics services, and diagnostic services like the Self Request Chest X-Ray Service.
Differentiator
Problem solved
Functional benefit
Brands
- Cancer SMART: A programme that recruits cancer champions to share health messages promoting cancer prevention, uptake of screening, and early diagnosis with their communities. Operated in partnership with Yorkshire Cancer Community.
Products and services
- Living with and Beyond Cancer Programme Programme supporting people living with and beyond cancer through personalised care, prehabilitation, rehabilitation and physical activity initiatives, delivered through NHS and partner organisations in West Yorkshire and Harrogate.
- Healthy Communities and Cancer Screening Community-focused initiatives including the Remove the Doubt campaign and learning disability cancer screening videos aimed at promoting early cancer diagnosis and screening uptake across underserved communities.
- NHS Lung Cancer Screening Programme Targeted Lung Health Checks programme providing screening services in Wakefield and Bradford areas to detect lung cancer early among eligible high-risk populations.
- Innovations Programme Annual funding competition supporting innovative projects that promote early cancer diagnosis and better care, distributing up to £800k of innovation funding to NHS, primary care and VCSE partners.
- Optimal Pathway Groups Clinical pathway optimisation groups, including the FIT (faecal immunochemical test) pathway for colorectal cancer diagnosis, coordinating best-practice cancer diagnostic and treatment pathways across the region.
- Cancer SMART / Cancer Champions Programme Volunteer training programme that equips community members to act as Cancer Champions sharing health messages promoting cancer prevention, screening uptake and early diagnosis within their local communities across West Yorkshire and Harrogate.
- Community Patient Panel Award-winning engagement panel of patients, carers and people affected by cancer that works with the Cancer Alliance to influence its work, decisions and delivery priorities.
- Workforce Development Programmes Cancer workforce career development initiatives including the Macmillan Development Programme for Cancer Clinical Nurse Specialists and the Aspirant Cancer Career Education Development Programme (ACCEND).
- Non Surgical Oncology Services Regional coordination of non-surgical oncology treatments across West Yorkshire and Harrogate, including chemotherapy, radiotherapy and immunotherapy services.
- Genomics and Inheritance Services Regional services addressing family history and genetic inheritance aspects of cancer risk and diagnosis across the West Yorkshire and Harrogate population.
- Self Request Chest X-Ray Service Diagnostic service allowing eligible patients aged 40+ registered with participating Leeds GPs to self-request chest x-rays for lung symptom assessment without a prior GP appointment.
- Patient Information Resources Comprehensive cancer-specific information covering breast, colorectal, gynaecological, head and neck, haematological, hepatobiliary, lung, oral, skin, upper GI, urological and rare cancers, plus resources for carers and dementia support.
Quantifiable outcome
- 150+ patients interviewed through Cancer Journeys programme
- +2 more outcomes
Companies that use West Yorkshire and Harrogate Cancer Alliance
Customer profileNamed customers14 records
Segments5 records
Ideal customer profiles2 records
West Yorkshire and Harrogate Cancer Alliance technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
West Yorkshire and Harrogate Cancer Alliance partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and minor.
- West Yorkshire Health and Care PartnershipcoreWest Yorkshire and Harrogate Cancer Alliance is proud to be part of the West Yorkshire Health and Care Partnership. The Cancer Alliance is the cancer programme of the West Yorkshire Integrated Care Board.
- Yorkshire Cancer CommunitycoreRegional patient-led charity and key partner in delivering Cancer SMART Champions programme, community patient panel, and various innovation initiatives.
- Yorkshire and Humber Innovation NetworkcoreCollaboration partner for annual innovation competition 2026/27 in conjunction with the West Yorkshire and Harrogate Innovation Award Scheme.
- Harrogate and District NHS Foundation TrustcorePartner in Coping with Cancer and Dementia Together project along with Dementia Forward and Leeds Beckett University.
- Dementia ForwardcoreCharity partner in Coping with Cancer and Dementia Together project addressing complex needs of people living with both cancer and dementia.
- Leeds Beckett UniversitycoreAcademic partner in Coping with Cancer and Dementia Together project, conducting research into practical patient-centred help.
- Kam's Corner CICminorPartner in 'Don't Be the One' prostate cancer awareness campaign addressing higher risk for black men, working to tackle health inequalities.
- Macmillan Cancer SupportcoreCharity partner providing support resources, development programmes for cancer nurses, and funding for cancer care initiatives.
- Six NHS Hospital TrustscoreCore delivery partners: Leeds Teaching Hospitals NHS Trust, Harrogate and District NHS Foundation Trust, Bradford Teaching Hospitals NHS Foundation Trust, Calderdale and Huddersfield NHS Foundation Trust, Airedale NHS Foundation Trust, Mid Yorkshire Teaching NHS Trust.
Scale indicators4 records
Recent moves3 records
Expansion highlights5 records
West Yorkshire and Harrogate Cancer Alliance competitors and assessment
Company assessmentOthers
- Macmillan Cancer Support: Major UK cancer charity that funds cancer workforce development, patient information, and care initiatives. Direct strategic partner of the Alliance through the Macmillan Development Programme for Cancer Clinical Nurse Specialists and ACCEND.
- Cancer Research UK: UK's largest cancer charity focused on research, prevention and early diagnosis. Operates as an adjacent enabler in the cancer ecosystem alongside Cancer Alliances, with overlapping interests in screening uptake and health inequalities.
Broad incumbents
- NHS England: Statutory parent commissioning body that funds and mandates the 21 Cancer Alliances. Comparable as the broader healthcare system operator that sets the policy framework and allocates resources across all Cancer Alliances.
Regional players
- Wessex Cancer Alliance: NHS England Cancer Alliance covering Hampshire, the Isle of Wight and Dorset. Similar model coordinating cancer services across multiple NHS trusts with innovation and patient engagement programmes.
- Greater Manchester Cancer Alliance: Another of the 21 NHS England Cancer Alliances, operating in Greater Manchester with the same mandate to transform cancer diagnosis, treatment and care. Directly comparable in mission, governance and programme structure, serving a different geography.
- Northern Cancer Alliance: NHS England Cancer Alliance covering the North East and North Cumbria. Operates the same model of partnership working with hospital trusts, primary care, and VCSE organisations across its regional footprint.
- Cheshire and Merseyside Cancer Alliance: NHS England Cancer Alliance covering Cheshire and Merseyside with identical statutory mandate. Comparable in programme scope including early diagnosis, living with and beyond cancer, and innovation funding.
- East of England Cancer Alliance: NHS England Cancer Alliance covering the East of England. Comparable in coordinating cancer pathways across a multi-trust geography and running innovation and screening initiatives.
- West Midlands Cancer Alliance: Large NHS England Cancer Alliance covering the West Midlands with comparable programme structure around personalised care, screening uptake, and workforce development.
- South Yorkshire Cancer Alliance: Neighbouring NHS England Cancer Alliance covering South Yorkshire and Bassetlaw. Operates analogous programmes including lung health checks, personalised care, and innovation competitions with NHS trusts in its region.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
West Yorkshire and Harrogate Cancer Alliance social profiles
Digital presenceWest Yorkshire and Harrogate Cancer Alliance compliance and trust
Trust signalCompliance1 record
West Yorkshire and Harrogate Cancer Alliance financial estimates
Financial estimateRevenue estimate
Valuation estimate
West Yorkshire and Harrogate Cancer Alliance leadership team
Management profileNumber of profiles
Profiles4 records
West Yorkshire and Harrogate Cancer Alliance funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
West Yorkshire and Harrogate Cancer Alliance M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about West Yorkshire and Harrogate Cancer Alliance
What does West Yorkshire and Harrogate Cancer Alliance do?
West Yorkshire and Harrogate Cancer Alliance is an NHS-funded cancer transformation programme that coordinates and improves cancer diagnosis, treatment and care across the West Yorkshire and Harrogate region. It delivers and oversees a portfolio of interconnected programmes including early diagnosis and screening (e.g., Targeted Lung Health Checks, FIT pathway), personalised care and living with and beyond cancer support, an annual innovation funding competition (up to £800k), workforce development (Macmillan CNS Development Programme, ACCEND) and community engagement through Cancer Champions and the Community Patient Panel. The offering is publicly funded, free at point of use, and directed at NHS Trusts, healthcare professionals, patients, carers and communities across the region.
Is West Yorkshire and Harrogate Cancer Alliance a public or private company?
West Yorkshire and Harrogate Cancer Alliance is a public company. It is classified as state government owned and is currently operating.
When was West Yorkshire and Harrogate Cancer Alliance founded?
West Yorkshire and Harrogate Cancer Alliance was founded in 2016. It employs 11 to 50 people.
Where is West Yorkshire and Harrogate Cancer Alliance based?
West Yorkshire and Harrogate Cancer Alliance is headquartered in Wakefield, England, United Kingdom, in the Europe region.
How does West Yorkshire and Harrogate Cancer Alliance make money?
One revenue line is on record: NHS England Funding.
Who are West Yorkshire and Harrogate Cancer Alliance's main competitors?
Others on record are Macmillan Cancer Support and Cancer Research UK. NHS England is listed as a broad incumbent. Regional players are Wessex Cancer Alliance, Greater Manchester Cancer Alliance, Northern Cancer Alliance, Cheshire and Merseyside Cancer Alliance, East of England Cancer Alliance, West Midlands Cancer Alliance and South Yorkshire Cancer Alliance.
Does West Yorkshire and Harrogate Cancer Alliance have an API?
No public API is recorded for West Yorkshire and Harrogate Cancer Alliance.
What industry is West Yorkshire and Harrogate Cancer Alliance in?
West Yorkshire and Harrogate Cancer Alliance's product category is Cancer Care Coordination Services. Its primary akta.pro industry code is HLAFAHAC, Oncology & Cancer Specialty Hospitals, with a secondary code of BPAGACAC, Community Health, Prevention & Health Education. Its NAICS code is 624 and its SIC code is 8000.